14-91307224-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001080414.4(CCDC88C):​c.3009A>G​(p.Leu1003Leu) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.565 in 1,612,236 control chromosomes in the GnomAD database, including 260,807 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23643 hom., cov: 32)
Exomes 𝑓: 0.57 ( 237164 hom. )

Consequence

CCDC88C
NM_001080414.4 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0160

Publications

20 publications found
Variant links:
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
CCDC88C Gene-Disease associations (from GenCC):
  • hydrocephalus, nonsyndromic, autosomal recessive 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • spinocerebellar ataxia type 40
    Inheritance: AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 14-91307224-T-C is Benign according to our data. Variant chr14-91307224-T-C is described in ClinVar as Benign. ClinVar VariationId is 158098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.016 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.583 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC88CNM_001080414.4 linkc.3009A>G p.Leu1003Leu splice_region_variant, synonymous_variant Exon 18 of 30 ENST00000389857.11 NP_001073883.2 Q9P219-1B4DZB8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC88CENST00000389857.11 linkc.3009A>G p.Leu1003Leu splice_region_variant, synonymous_variant Exon 18 of 30 5 NM_001080414.4 ENSP00000374507.6 Q9P219-1

Frequencies

GnomAD3 genomes
AF:
0.555
AC:
84312
AN:
151984
Hom.:
23633
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.548
Gnomad AMI
AF:
0.628
Gnomad AMR
AF:
0.495
Gnomad ASJ
AF:
0.521
Gnomad EAS
AF:
0.367
Gnomad SAS
AF:
0.391
Gnomad FIN
AF:
0.633
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.588
Gnomad OTH
AF:
0.523
GnomAD2 exomes
AF:
0.532
AC:
132116
AN:
248246
AF XY:
0.526
show subpopulations
Gnomad AFR exome
AF:
0.546
Gnomad AMR exome
AF:
0.518
Gnomad ASJ exome
AF:
0.508
Gnomad EAS exome
AF:
0.367
Gnomad FIN exome
AF:
0.626
Gnomad NFE exome
AF:
0.584
Gnomad OTH exome
AF:
0.550
GnomAD4 exome
AF:
0.566
AC:
826433
AN:
1460134
Hom.:
237164
Cov.:
42
AF XY:
0.560
AC XY:
406632
AN XY:
726404
show subpopulations
African (AFR)
AF:
0.542
AC:
18128
AN:
33466
American (AMR)
AF:
0.514
AC:
22981
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.509
AC:
13309
AN:
26130
East Asian (EAS)
AF:
0.395
AC:
15693
AN:
39694
South Asian (SAS)
AF:
0.388
AC:
33441
AN:
86242
European-Finnish (FIN)
AF:
0.627
AC:
32942
AN:
52518
Middle Eastern (MID)
AF:
0.508
AC:
2897
AN:
5700
European-Non Finnish (NFE)
AF:
0.589
AC:
654190
AN:
1111340
Other (OTH)
AF:
0.544
AC:
32852
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
17957
35914
53871
71828
89785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17892
35784
53676
71568
89460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.555
AC:
84369
AN:
152102
Hom.:
23643
Cov.:
32
AF XY:
0.549
AC XY:
40805
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.548
AC:
22744
AN:
41476
American (AMR)
AF:
0.495
AC:
7567
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.521
AC:
1807
AN:
3470
East Asian (EAS)
AF:
0.367
AC:
1899
AN:
5174
South Asian (SAS)
AF:
0.390
AC:
1882
AN:
4820
European-Finnish (FIN)
AF:
0.633
AC:
6689
AN:
10572
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.588
AC:
39955
AN:
67986
Other (OTH)
AF:
0.520
AC:
1099
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1971
3941
5912
7882
9853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.562
Hom.:
40784
Bravo
AF:
0.545
Asia WGS
AF:
0.399
AC:
1393
AN:
3478
EpiCase
AF:
0.567
EpiControl
AF:
0.565

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia type 40 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hydrocephalus, nonsyndromic, autosomal recessive 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
4.0
DANN
Benign
0.36
PhyloP100
-0.016
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1970912; hg19: chr14-91773568; COSMIC: COSV66237429; API